Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada flag Canada · Delayed Price · Currency is CAD
3.050
-0.060 (-1.93%)
Aug 29, 2025, 3:59 PM EDT
-1.93%
Market Cap98.54M
Revenue (ttm)144.11M
Net Income (ttm)1.10M
Shares Out32.31M
EPS (ttm)0.04
PE Ratio78.65
Forward PE44.85
Dividendn/a
Ex-Dividend Daten/a
Volume25,500
Average Volume59,647
Open3.100
Previous Close3.110
Day's Range3.010 - 3.100
52-Week Range1.710 - 5.560
Beta2.01
RSI58.08
Earnings DateAug 6, 2025

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection ... [Read more]

Sector Healthcare
Founded 2018
Employees 91
Stock Exchange Toronto Stock Exchange
Ticker Symbol MDP
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.